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L. acidophilus DDS1-10 was encapsulated using an alginate, potato starch and type 4
resistant starch (RS4) matrix. The wall material was optimized by varying levels of
alginate (1.6 to 4.4%), while maintaining potato starch and RS4 ratio fixed at 2, and the
total solid content at 5%. Particles were prepared using an emulsion and an extrusion
method. Particles obtained from the emulsion method were smaller with a non-uniform
distribution in size while those obtained by the extrusion method were bigger and
uniform in size. The emulsion method did not seem to offer protection to the probiotic
cells against pH, bile salt and temperature. However, the particles obtained by the
extrusion method provided protection against the effects of pH and bile salts. The
particles produced by extrusion were incorporated into two food systems of varying pH
levels. Promising results were observed in the milk system; however encapsulation did
not provide significant protection when cells were introduced to acai juice during 16 days
of storage.

Acknowledgements
I wish to extend my deepest gratitude to my advisor, Dr. Andréia Bianchini. Thank you
very much for your selfless help and patience with me. You have provided me with
priceless guidance and knowledge to solve the problems. It has been such a pleasure to be
your student. I would also like to thank my co-advisor, Dr. Jayne Stratton, who has been
helping me to improve myself and always give me instructive advice to light my
research. I could not finish my research without your help especially in the lab. Thank
you for being so patient with me all the time. I would also like to thank Dr. Rolando
Flores, who always cares about my research and self-development. Thank you for giving
me courage to start my graduate study here and keep exploring my potential. I would also
like to thank you for supporting my last year of study here.
I am grateful with our outstanding microbiological lab technician Robin Krokstrom, and
graduate students Bismarck Martinez, Luis Sabillon, Rodrigo Mendoza, and Yulie
Meneses. I cannot finish my research without any of you.
I would also like to thank my former advisor Dr. Wajira Ratnayake who has advised me
for my first two years of study here, and also initiated this program so I could have the
chance of exploring this fascinating field.
I wish to thank my parents who always love me and support me unconditionally. Thank
you for always stand by my side and give me courage to come to the U.S. to complete my
study. I love you!

Table of contents
Acknowledgements ............................................................................................................ iii
Table of contents ................................................................................................................ iv
List of tables ..................................................................................................................... viii
List of figures ..................................................................................................................... ix
Chapter 1. Literature review ............................................................................................... 1
1.1 Microencapsulation ................................................................................................... 1
1.2 Microencapsulation techniques ................................................................................. 2
1.2.1 Emulsion method ............................................................................................... 3
1.2.2 Extrusion method ............................................................................................... 4
1.2.3 Other encapsulation methods ............................................................................. 4
1.3 Wall material selection ............................................................................................. 6
1.3.1 Alginate .............................................................................................................. 7
1.3.2 Resistant starch type 4 ....................................................................................... 8
1.3.3 Potato starch ....................................................................................................... 9
1.3.4 Other wall materials ......................................................................................... 10
1.4 Probiotics ................................................................................................................ 12
1.4.1 Lactobacillus acidophilus ................................................................................ 12

1.5 Encapsulation of probiotics..................................................................................... 14
1.6 Release mechanism ................................................................................................. 15
1.7 Physicochemical characterization of microparticles ............................................... 16
1.7.1 Particle size distribution................................................................................... 16
1.7.2 Morphology of microparticles ......................................................................... 17
1.8 Objectives ............................................................................................................... 17
1.9 References ............................................................................................................... 19
Chapter 2 Materials and methods ..................................................................................... 28
2.1 L. acidophilus.......................................................................................................... 28
2.2 Preparation of cell suspension ................................................................................ 28
2.3 Preparation of encapsulation matrix ....................................................................... 29
2.4 Preparation of particles using the emulsion method ............................................... 30
2.5 Preparation of particles using extrusion method ..................................................... 31
2.6 Analysis of physical properties of particles ............................................................ 31
2.7 Release and enumeration of the encapsulated cells ................................................ 32
2.8 Optimization of encapsulation matrix material composition .................................. 32
2.9 Acid and bile salt resistance of optimumized particles ........................................... 34
2.10 Resistance of optimumized particles to temperature ............................................ 35
2.11 Survivability test of optimumized particles .......................................................... 35

2.12 Shelf life test of optimized particles ..................................................................... 36
2.13 Statistical analysis ................................................................................................. 36
Chapter 3 Results and discussion ...................................................................................... 39
3.1 Emulsion method .................................................................................................... 39
3.1.1 Choosing wall material composition ............................................................... 39
3.1.2 Physical properties of encapsulated particles .................................................. 40
3.1.3 Challenging encapsulated L. acidophilus with pH, bile salt and temperature . 41
3.2 L. acidophilus encapsulated by the extrusion method ............................................ 47
3.2.1 Wall material composition ............................................................................... 47
3.2.2 Particle size ...................................................................................................... 48
3.2.3 Hardening time test .......................................................................................... 49
3.2.4 Challenging encapsulated L. acidophilus with pH and bile salt test................ 51
3.2.5 Challenging survival of encapsulated L. acidophilus under different pH and
temperature conditions for 7 days ............................................................................. 55
3.2.6 Survival of encapsulated L. acidophilus in low pH beverages ........................ 57
3.3 References ............................................................................................................... 61
Chapter 4 Conclusions and future research ...................................................................... 69
4.1 Conclusions ............................................................................................................. 69
4.2 Future work ............................................................................................................. 70
Appendix A. Bacterial reduction of encapsulated particles produced from emulsion
method after incubation in MRS at pH 2 for 3 hours ....................................................... 72

Appendix B. Bacterial reduction of encapsulated particles produced from extrusion
method after incubation in MRS at pH 2 for 3 hours. ...................................................... 73

List of tables
Table 1.1 Comparison of microencapsulation techniques ............................................... 26
Table 1.2 Major steps for encapsulation technique .......................................................... 27
Table 1.3 applications of encapsulating probiotics on yogurt with different techniques . 27
Table 2.1. Selected compositions of wall material........................................................... 37
Table 3.1 Survival of encapsulated particles (cell reduction) obtained from emulsion
method after 3 hours incubation in MRS broth at pH 2. ................................................... 39
Table 3.2 Bacterial counts of encapsulated and free L. acidophilus over 6 hour of
incubation in bile salt at different levels (0.5, 1.0, and 2.0%). ......................................... 45
Table 3.3 Survival of encapsulated and free L. acidophilus after incubation over 24 hour
incubation in MRS broth at 25°C (log CFU/g) ................................................................. 46
Table 3.4 Survival of encapsulated and free L. acidophilus over 24 hour incubation in
MRS broth at 37°C (log CFU/g). ...................................................................................... 46
Table 3.5 Survival of encapsulated and free L. acidophilus over 3 hour incubation in
MRS broth at 50°C (log CFU/g) ....................................................................................... 47
Table 3.6 Survival of encapsulated particles (cell reduction) obtained from extrusion
method after 3 hours incubation in MRS broth at pH 2. ................................................... 48
Table 3.7 Particle size (mean diameter) of the encapsulated particles from extrusion. ... 49
Table 3.8 Effect of hardening time on survival of encapsulated and free L. acidophilus
after incubation in MRS broth at pH 2 for 3 hours. .......................................................... 50
Table 3.9 Bacterial counts of encapsulated and free L. acidophilus over 6 hour of
incubation in bile salt at different levels (0.5, 1.0, and 2.0%). ......................................... 53
Table 3.10 Survival of encapsulated and free cells in milk and juice (log CFU/g). ........ 59

List of figures
Figure 2.1 Absorbance of MRS broth and L. acidophilus growth curve. ........................ 37
Figure 2.2 Particles obtained using emulsion method under microscopy........................ 38
Figure 2.3 Particles obtained using extrusion method . ................................................... 38
Figure 3.1 Particle size distribution of particles produced by the emulsion method (1.6%,
3.0%, 4.4%- alginate level; potato starch: RS4=2). .......................................................... 41
Figure 3.2 Survivability of encapsulated and free L. acidophilus over 24 hour of
incubation at different pH values. ..................................................................................... 43
Figure 3.3 Effect of pH on survival of encapsulated cells (cell reduction) after incubation
in MRS broth at pH 2.0, 4.0, 4.5, and 5.0 for 24 hours. ................................................... 51
Figure 3.4 Survival of encapsulated and free cells during incubation for
7 days at 7°C. .................................................................................................................... 56
Figure 3.5 Survival of encapsulated and free cells during incubation for
7 days at 25°C. .................................................................................................................. 57

Chapter 1. Literature review
1.1 Microencapsulation
Microencapsulation is the process by which food ingredients, enzymes, cells or other
materials are incorporated in small capsules (Gibbs et al. 1999). The capsule coatings are
referred to as wall, shell, or carrier. The entrapped material can be described as the core,
fill, actives, or payload (Augustin et al. 2001). Microencapsulation first appeared in the
market as part of the manufacturing process of carbonless copy paper (White 1998).

During encapsulation, the core material is usually enclosed by the wall material.
Sometimes, there is no obvious boundary between the wall and core material, with both
mixed together in what is called the matrix. The shape of the particles can be regular or
irregular. Since the particle is usually spherical to elliptical, it is also called a
microsphere. If the capsule has a gel-like structure, it is named gel-bead (Amir
Mortazavian 2007; Gibbs et al. 1999; Gouin 2004). The surface of the particles can be
smooth or rough. There might also be cracks on the particles (Sheu and Marshall 1993).
The surface of the particles can be porous too, which usually lower the encapsulation
efficiency (Amir Mortazavian 2007). In this case, a second wall or multi-walls can be
used to strengthen the inner wall and increase the encapsulation efficiency (Krasaekoopt
et al. 2004).

The size of the particles varies with the method applied for encapsulation. Smaller sizes
are preferred because they allow for better transportation of nutrients and oxygen, better
mechanical strength and better dispersion (Chicheportiche and Reach 1988; Leblond et
al. 1999). Singer and Dunn (1990) reported that particles that are smaller than 3 µm are
not perceived by the tongue.

Microencapsulation is used for several different reasons. It is used to protect the
compound or biological cells from the surrounding environment (heat, oxygen, moisture);
disguise unpleasant odor, color or taste of the core material, or convert liquid into powder
for ease of handling. It can also be used to better disperse core materials in the product;
and control the release of the core material at supposed sites and times (Desai and Park
2005; Dziezak 1988(Desai and Park 2005; Dziezak 1988; Shahidi and Han 1993).

1.2 Microencapsulation techniques
There are various techniques available for microencapsulation. They are normally
classified into three categories: (1) Physical techniques (Spray drying, spray chilling,
extrusion, centrifugal extrusion, fluid bed coating); (2) Chemical techniques (Interfacial
polymerization, polymerization); and (3) Physicochemical techniques (Coacervation).
The choice of method is dependent mainly on the wall material, core material, equipment
available, cost consideration, application, and scale of production (Gibbs et al. 1999;

Gouin 2004; Krasaekoopt et al. 2004). Table 1.1 shows the advantages and disadvantages
of some of the encapsulation techniques, while Table 1.2 shows the major processes
involved in some of the encapsulation techniques.

1.2.1 Emulsion method
The emulsion method is achieved by adding the wall material and core material dropwise into an oil phase to form an emulsion, followed by hardening of the wall material
with the addition of a gelling agent or a crosslinking agent (Champagne and Fustier
2007). This method is costly because of the use of vegetable oil. Using this method, Sheu
and Marshall (1993) developed a procedure to entrap L. bulgaricus by mixing it with 3%
sodium alginate and suspending it into oil which contains 0.2% Tween 80. The particles
produced protected the bacteria and improved survival in ice milk by 40% (Sheu and
Marshall 1993) .

In the emulsion method, the size of the particles is influenced by the speed of agitation
and the type of emulsifier used. Smaller sized particles are desired for various reasons:
They transport core material more efficiently, disperses better, and carry better
mechanical strength (Chicheportiche and Reach 1988; Sugiura et al. 2005). The bead size
achieved by the emulsion method varies from 25𝜇m to 2mm (Krasaekoopt et al. 2003).

Capela et al. (2007) indicated that a bead size of 39.2𝜇m could be achieved by using a
homogenizing speed of 13,500 rpm for 4 minutes.

1.2.2 Extrusion method
Extrusion is the simplest and most common technique for forming hydrocolloid particles
(King 1995). The size of the particles obtained with the extrusion method (2-5mm) is
larger than that obtained from the emulsion method (25µm- 2mm) (Sheu and Marshall
1993; Sultana et al. 2000). In this process, the core material and alginate pass through a
syringe needle and drop into the hardening solution (containing cations such as calcium).
The particles are then formed immediately when the drop comes in contact with the
hardening solution. The size of the particles is dependent on the size of the needle, and
the distance between the needle and the hardening solution (de Vos et al. 2010; Gouin
2004; Krasaekoopt et al. 2003). The advantage of the extrusion technology is that the
wall material could be a shell over the core material, or the wall material and core
material could be produced as a matrix (Gibbs et al. 1999).

1.2.3 Other encapsulation methods
Spray-drying is the most widely used and studied technology in the food industry for
microencapsulation because of its suitability for economical large-scale industrial

application (Dziezak 1988). The first spray-dryer was constructed in 1878 for
pharmaceutical use (Hayashi 1989). The one-step continuous process and readily
available equipment allows for easy operation and reproducibility. Encapsulation by this
technology involves the atomization of an aqueous suspension into a drying gas, the
water evaporates due to high temperature, then the dry particles could be collected
(Tonon et al. 2011). The process is controlled by the feed rate, inlet and outlet
temperature, and gas flow (Rokka and Rantamaki 2010). Spray drying was once
considered an inferior method for encapsulating probiotics since the survival rate of the
bacteria was low due to the dehydration and thermal inaction of the microorganism (Fu
and Etzel 1995; Saarela et al. 2000). However, a relatively high survival rate of
Bifidobacterium was reported when utilizing an inlet temperature of 100℃ and an outlet
temperature of 45℃ with modified starch as wall material (O'Riordan et al. 2001). But
the drawback of this modified method is that it affects the ability of the probiotics to
resist the gastrointestinal environment (Del Piano et al. 2008).

Spray chilling is similar to spray drying except that the atomized core material and wall
material suspension are chilled by cooled air instead of heated air (Nazzaro et al. 2012).
The cool air leads to solidification of the wall material around the core material since the
melting point of the wall material is usually higher than the air temperature (Chambi et al.
2008; Champagne and Fustier 2007; Pedroso et al. 2012). The wall material is usually
fractionated or hydrogenated vegetable oil which has a melting point ranging from 32-

42℃ (Risch 1995). Therefore, the release of the core material from the microsphere
produced by this method can be controlled by the temperature. Frozen liquid, heatsensitive materials and water-insoluble materials can be used in this method (Gibbs et al.
1999). Spray chilling is considered to be the cheapest encapsulation technique (Gouin
2004).

1.3 Wall material selection
Various substances can be used as wall material to entrap, coat, or encapsulate. However,
only a few of them are regarded as “generally recognized as safe” (GRAS) materials.
Numerous encapsulation techniques are limited because of the lack of GRAS materials.
Food regulations are stricter than the ones applied in the pharmacy industry when
regarding wall material choice (Wandrey et al. 2010). Commonly used wall materials are
alginate, starch, xanthan gum, cellulose, gelatin, chitosan and ƙ-carrageenan. The choice
of the wall material is dependent on the method adopted and the core material used.

Ding and Shah (2009) tested the protection role of alginate, xanthan gum, and
carrageenan gum when encapsulating Lactobacillus rhamnosus under acidic conditions
over 8 hours of incubation. They found that the viability of the probiotics was reduced by
3.63 log CFU/mL, respectively, compared to free cells which showed a reduction of 6 log
CFU/mL.

1.3.1 Alginate
Alginates are naturaly occurring polysaccharides either extracted from seaweed or
produced by bacteria (Gombotz and Wee 1998). The alginate molecule is a block
copolymer composed of sequential M units (1,4-linked ß-D-mannuronic acid) and G unit
(α-L-gluluronic acid), with the sequential distribution depending upon the source of the
alginate (Martinsen et al. 1989). Divalent cations such as Ca2+ tend to bind to the G unit
(Krasaekoopt et al. 2003), inducing ionic interchain bridges, which results in an egg-box
structure in alginate gel (Rees 1981). Other divalent cations such as Pb2+, Co2+ and Ni2+
are not used for food applications because of their toxicity. Alginate is the most used
biopolymer for encapsulation (Saarela et al. 2000). The unique properties of alginate such
as a high gel porosity and ease of processing at room temperature make it an ideal matrix
material for encapsulation (Gombotz and Wee 1998).

Various reports have indicated the success of using alginate as wall material alone or in
combination with others. Alginate as wall material has been tested with concentrations
ranging from 1% to 3%, along with 0.05-1.5M CaCl2 (Chandramouli et al. 2004; Cui et
al. 2000; Kearney et al. 1990; Krasaekoopt et al. 2006; Prevost and Divies 1988; Sheu
and Marshall 1993). Jankowski et al. (1997) tested 0.6% sodium alginate with 0.05, 0.10,
and 0.30 M CaCl2 and found out that the viability and fermentation ability of
L.acidophilus during yogurt manufacture increased compared to unencapsulated bacteria.

However, alginate is very sensitive to acid. It has been reported to degrade under acidic
conditions because the cross-linking network suffers a reduction in molecular weight
(Mumper et al. 1994). It is because the hydration links between the M and G units are
broken. The network then becomes loose, which fastens the degradation of alginate
(Gombotz and Wee 2012).

An alginate gel is very porous, which usually requires another coating agent to enhance
protection of the core material, especially in acidic conditions (Klein et al. 1983;
Taqieddin and Amiji 2004). Higher than 5% of alginate is usually avoided because of
handling difficulties during processing (Gombotz and Wee 2012). The low viscosity of
the alginate solution lacks mechanical and physical stability (Peirone et al. 1998;
Smidsrod and Skjakbraek 1990).

1.3.2 Resistant starch type 4
Starches are polysaccharides that are composed of a number of monosaccharides or sugar
molecules linked with α-D-(1-4) or α-D-(1-6) linkages. It consists of amylose, which is a
linear polymer of glucose with α-D-(1,4) linkages, and amylopectin, which is a branched
molecule with α-D-(1-4) and α-D-(1-6) linkages (Sajilata et al. 2006). Resistant starch is
defined as a small fraction of the starch, and starch degradation products that are resistant
to digestion in the small intestine of healthy humans (Asp 1992). There are four types of

resistant starch. Resistant starch type 1 (RS1) is a physically inaccessible starch trapped
within whole grains or seeds. Resistant starch type 2 (RS2) is a high amylose granular
starch from certain plants. Resistant starch type 3 (RS3) is retrograded starch after
gelatinization, and the linearly/cross-linked starch that is difficult to hydrolyze by αamylose is called resistant starch type 4 (RS4) (Lee et al. 2007). The ability to resist
digestion by pepsin and pancreatin-bile are found in 82% of RS4 (Lee et al. 2007).

Starch has long been used as the wall material for encapsulation since the starch granule
is an ideal surface for attachment of probiotic cells. Additionally, resistant starch can also
offer the benefit of not being digested, which allows it to reach the colon where it is
fermented (Kritchevsky 1995). Sultana et al. (2000) incorporated Hi-Maize starch into
alginate and improved the viability of probiotics compared to encapsulation without
starch. Resistant starch can also be used as an adherence surface for the probiotics during
processing, storage and transit through the upper gastrointestinal tract (Anal and Singh
2007).

1.3.3 Potato starch
Potato Starch consists of starch particles that are oval or spherical in shape with a
diameter of 5-100 µm. The pasting temperature is around 60-65°C and it has very high

pasting viscosity. The film strength, flexibility and solubility obtained with potato starch
are very high, and provides solutions with high clarity (BeMiller 2009).

The main purpose of using potato starch during encapsulation is to take advantage of its
adherence capacity. Crittenden et al. (2001) investigated the adherent capacity of the
Bifidobacterium strains to adhere to potato starch and a few other starches. They found
that the binding capacity was related to the surface area of the granules and was not
affected by bile salt. Based on their results, they have proposed the use of potato starch
for encapsulation technology.

The VTT Technical Research Center of Finland carried a study to encapsulate the lactic
acid bacteria with potato starch. Large potato starch granules (50-100 µm) were
enzymatically treated to obtain a porous structure and then used as carrier. During
encapsulation, lactic acid bacteria adhere to the pores of the potato starch. With another
coating of amylose, the lactic acid bacteria could survive at least 6 months at room
temperature (Mattila-Sandholm et al. 2002).

1.3.4 Other wall materials
Chitosan is a linear polysaccharide essentially composed of ß (1-4) glucosamine units
together with N-acetylglucosamine units to form a linear structure (Peniche et al. 2003).

The cross-link network is formed in the presence of anions or polyanions (Burgain et al.
2011). During encapsulation, it is preferably used as a second coating due to its low
encapsulation efficiency (Mortazavian et al. 2008). Chitosan is commonly used along
with alginate. Lee et al. (2004) tested the effect of three different chitosan coatings on
alginate beads. They indicated that chitosan with high molecular weight showed higher
survival of L. bulgaricus after exposure to simulated gastric and intestinal juice,
compared to alginate alone as carrier.

Gellan gum and xanthan gum are used in combination to form beads during
encapsulation. Gellan gum is a microbial polysaccharide derived from Pseudomonas
elodea(Jansson et al. 1983). It has a tetrasaccharide repeating unit consisting of two ß-Dglucose, one ß-glururonic acid and one α-L-rhamnose residue (Grasdalen and Smidsrod
1987). Xanthan gum is a heteropolysaccharide consisting of two glucose units, two
mannose units, and one glucuronic acid unit (Garcia-Ochoa et al. 2000). Gellan gum and
xanthan gum used together as carriers show high resistance to acidic environments
compared to alginate. Sun and Griffiths (2000) indicated that the viability of the
encapsulated bifidobacteria decreased only 0.67 log CFU/mL, while the free cells
dropped from 1.23×109 CFU/mL to an undetectable level after 30 minutes of incubation
at pH 2.5.

Ƙ-carrageenan is a natural polymer and is commonly used in the food industry (Burgain
et al. 2011). The core material is added to a solution containing this polymer at 40-50°C.
After the mixture is cooled down to room temperature, the gelation occurs. Particles are
then stabilized by the addition of potassium ions (Krasaekoopt et al. 2003). Dinakar and
Mistry (1994) indicated that the encapsulated Bifidobacterium bifidum maintained
viability for as long as 24 weeks during cheddar cheese ripening.

1.4 Probiotics
Probiotics are defined as "live microbial supplements that beneficially affect the host by
improving its intestinal microbial balance" (Fuller 1989). Health claims on probiotics
include anti colon cancer properties, reduced risks of irritable bowel syndrome, and
prevention of inflammatory bowel disease (Santosa et al. 2006; Wollowski et al. 2001).
The probiotic effect mechanisms are attributed to the production of acid, or bacteriocins,
reinforcement of body’s natural defense, and competition with pathogens (Krasaekoopt et
al. 2003). The probiotics obtained from food sources must survive passage through the
upper gastrointestinal (GI) tract and function in the gut environment to achieve the
defined health benefits (Saarela et al. 2000).

1.4.1 Lactobacillus acidophilus

Lactic acid bacteria (LAB) are a group of bacteria that are gram-positive, nonsporeforming, facultative aerobes, cocci or rods, which produce lactic acid as the major
end product during the fermentation of carbohydrates (Sebastian et al. 2011). LAB used
as probiotics prevent adherence, establishment, and replication of certain pathogens
(Naidu et al. 1999). The main therapeutic and health benefits of L. acidophilus are that
they enhance the immune system, and prevent intestinal infections, diarrheal disease,
colon cancer and upper gastrointestinal tract diseases (Kailasapathy and Chin 2000). It
has been reported that certain isolated strains of Lactobacillus influence the metabolic
activity of the resident microflora in the human gut (Lee and Salminen 1995). Gilliland
et al. (1985) reported that L. acidophilus had the ability to resist bile salt and decrease
cholesterol levels. L. acidophilus is one of the most popular bacteria used as probiotics
for human consumption (Amir Mortazavian 2007). In the United States, over 80% of the
yoghurt in the market contains L. acidophilus (Gomes and Malcata 1999). However,
Shah et al. (1995) indicated that L. acidophilus showed a constant decline in viable cells
during storage in commercial yogurt.

The viability of L. acidophilus showed a 6-log CFU/mL reduction after 2 hours of
incubation at pH 2.0. It also has shown a reduction from 10.2-log CFU/mL to 6.3-log
CFU/mL after 4 hours of exposure to bile salt (Ding and Shah 2007). Schillinger (1999)
isolated L. acidophilus from novel-type probiotic dairy products, and found that four out
of eight mild yogurt contained less than 104 CFU/g at the end of storage (best before use

day). Therefore, encapsulation may provide the protection needed to retain cell viability
of probiotics, such as L. acidophilus, when incorporated them into food system,
especially acidic foods.

1.5 Encapsulation of probiotics
The ability of beneficial microorganisms to survive GI transit and multiply in the host
strongly influences their probiotic benefits. The bacteria should be metabolically stable
and active in the product, survive passage through the upper digestive tract in large
numbers, and have beneficial effects when in the intestine of the host (Gilliland 1989).
Adequate numbers of viable cells are required to be consumed in order to transfer the
probiotic effects to consumers. It is suggested that the product should contain at least 105
active cells per gram of probiotics to provide the desired benefits (Kebary 1996).
However, a low viability of probiotics in dairy products has been indicated by various
reports (Gilliland and Speck 1977b; Klaver et al. 1993; Kneifel et al. 1993; Micanel et al.
1997; Phillips et al. 2006; Rybka and Kailasapathy 1995; Schillinger 1999; Shah and
Lankaputhra 1997). Vinderola et al. (2000) reported that the viability of Bifidobacterium

and L. acidophilus in Argentinian yogurt were reduced by 1-4 log after 4 weeks of
storage.

Encapsulation, therefore, could provide probiotics with a barrier to resist adverse food
environments, since it has been widely used to protect microorganisms from
environmental and physiological degradation (Corbo et al. 2011; Lim and Moss 1981). It
has been proven that encapsulation increased the viability of microorganisms in both
dairy products and the intestinal tract by simulated digestion. Table 1.3 shows successful
examples of probiotic encapsulation using different methods with the ultimate goal of
applying them in yogurt. Lee and Heo (2000) found that the death rate of B. longum
decreased proportionally with increased bead size and alginate concentration after
exposure to simulated gastric juice and bile salt solution. Chavarri et al. (2010) also found
that the encapsulated B. bifidum showed significantly decreased death rate after exposure
to simulated gastric conditions (pH 2.0, 2h) and bile solution (3%, 2h) when compared
with free cells.

1.6 Release mechanism
To determine viability in encapsulated material, bacteria cells need to be released from
the beads. When the wall material contains alginate, the cross-linking network can be
broken by the removal of cation ions (Ferreira Almeida and Almeida 2004). To achieve

this, chelating agents such as ethylene glycol tetraacetic acid, lactate, citrate, phosphate or
a high concentration of ions such as Na+ or Mg2+ can be used (Gombotz and Wee 2012).
Sheu and Marshall (1993) tested the effect of pH of phosphate buffer ranging from 4.88.5 on the release of bacterial cells and found no significant differences among the pHs
tested. They also found that the cells reached plateau at ten minute with phosphate buffer
(0.05M, pH 4.8-8.5). Higher concentrations of phosphate buffer further shortens the
release time to 5 minutes.

1.7 Physicochemical characterization of microparticles
1.7.1 Particle size distribution
Laser diffraction is commonly used to determine the particle size of encapsulated
materials since it is efficient and repeatable. This method also characterizes volume size
distribution (Merkus 2009). Hyndman et al. (1993) tested the mean diameter of the
microparticles after encapsulation of Lactococcus lactis in gelatin using a particle size
analyzer. Brauss et al. (1999) determined the particle size of casein-fat droplets in yogurt
using the same method to reveal the connection between fat content and flavor release.

1.7.2 Morphology of microparticles
It is important to study the morphology of microparticles to check the aggregation and
damage on the surfaces of particles. When adopting the emulsion method, the
morphology of the microparticles are easily affected by processing changes (speed of
adding the calcium chloride, mixing speed, etc.) (Sheu and Marshall 1993). Optical and
electron microscopy are widely used to observe the size and shape of particles that are 0.2
µm or larger. Scanning electronic microscopy (SEM) is commonly used to study the
surface morphology, such as pores and internal structures by viewing cross-sections of
the beads (Zhang et al. 2010).

1.8 Objectives
Microencapsulation technology has been extensively used since its first appearance, with
the most well-developed techniques being used by the pharmaceutical industry. In the
food industry, research is now focusing on flavor delivery, while the area of
encapsulating functional ingredients, which is a huge market, is still waiting for
expansion. Probiotics as a functional ingredient has attracted much attention with recent
consumer trends that promote consumption of more natural and beneficial diets.
Therefore, there is a good opportunity to explore new encapsulation approaches of
probiotics. Some fundamental research on encapsulation of L. acidophilus encapsulation
has been accomplished; however, survival is normally low and inconsistent, and

applications in food systems are not well-studied. Therefore, the goal of this research is to
encapsulate Lactobacillus acidophilus DDS 1-10 in food grade wall material with both
emulsion and extrusion method, to increase the survivability of the probiotics and to
incorporate them into food systems.

The specific objectives are to:
1. Select the best alginate-starch mixture/composition to encapsulate Lactobacillus
acidophilus DDS 1-10.
2. Optimize processing conditions to prepare encapsulated probiotics with maximum
encapsulation efficiency with both emulsion and extrusion methods.
3. Evaluate and maximize the viability of the encapsulated cells.
4. Verify the stability of particles in selected conditions (pH, bile salt, and
temperature) with particles obtained from both emulsion and extrusion methods.
5. Incorporate the particles obtained from both emulsion and extrusion method and
investigate their behavior during storage.
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Table 1.1 Comparison of microencapsulation techniques
Technique
Advantage
Emulsion
Easy to scale up
Mild process
Spray drying
Economical
Well developed
Spray chilling
Temperature controlled
Inexpensive
Extrusion
Simple process
Uniform particle size

Disadvantage
Non-uniform particle size
Expensive
Limited wall materials
High temperature
Fat as wall material
Special storage condition
Difficult to scale up
Limited wall materials

Reference
(Krasaekoopt et al. 2003)
(Gouin 2004)
(Pedroso et al. 2012)
(Gouin 2004)

Table 1.2 Major steps for encapsulation technique
Technique
Major process
Emulsion
1. Cell is dispersed in the wall material
2. Mixture is added dropwidse into oil to form emulsion
3. Mixture is then solidified to form particles
Spray
1. Preparation of the wall material solutions with cells
drying
2. Atomization of the mixture into spray
3. Drying of the spray
4. Separation of the dry particles
Extrusion

Spray
chilling

1.
2.
3.
1.
2.
3.
4.

Preparation of wall material solution with cells
Extrusion of the mixture through syringe into the hardening solution
Formation of the particles
Preparation of the wall material solutions with cells
Contact with cooled air
Solidification of the particles
Separation of the dry particles

Table 1.3 applications of encapsulating probiotics on yogurt with different techniques
Technique
Wall material
Core material
Emulsion
Ƙ-carrageenan
B. longum
Spray drying
85% milk fat
B. breve
5-15% whey protein
Extrusion
2% sodium alginate
L. acidophilus
Spray chilling
Palm oil
L.acidophilus

Reference
(Adhikari et al. 2003)
(Picot and Lacroix 2004)
Krasaekoopt et al. (2006)
(Pedroso et al. 2012)

Chapter 2 Materials and methods
2.1 L. acidophilus
All the glassware and solutions used for the experiments were autoclaved at 121° C for
15 min. The probiotic strain Lactobacillus acidophilus DDS 1-10 (L. acidophilus) was
obtained from a commercial probiotic supplier (Nebraska Cultures, Walnut creek, CA).
From a frozen stock culture, an aliquot of 100 μL L. acidophilus was streaked on De Man
Rogosa Sharp agar (MRS, Acumedia, Neogen Corporation, Lansing, MI). Plates were
then incubated anaerobically (Mitsubishi, Tokyo, Japan) for 24 hours at 37°C. Gram stain
was then performed on single colonies. Colonies with the expected morphology were
transferred and grown overnight at 37 °C in MRS broth (Acumedia, Neogen Corporation,
Lansing, MI). Sterile glycerol (7%, v/v) was added to the broth and 1 mL aliquots were
stored at -80 °C for future use.

2.2 Preparation of cell suspension
Cultures used for encapsulation were grown for 24 hours by adding 100 μL of a stock
culture of L. acidophilus stock culture into 9 mL MRS broth and incubating at 37°C
anaerobically. They were then transferred to 500 mL MRS broth and incubated for 48
hours at 37°C anaerobically. The optical density of MRS broth (with cells) were
measured at 650 nm using a Spectronic 20D+ spectrophotometer (Spectronic

Instruments, Thermo Fisher Scientific, Waltham, MA), with MRS broth (without cells)
as a blank. Based on the reading, the volume of the MRS broth (with cells) used were
determined by comparison with growth curves previously obtained for L. acidophilus
(Figure 2.1). Cell pellets were then harvested using a Sorvall Legend XTR centrifuge
(Thermo Scientific, Hampton, NH) at 2780×g for 8 minutes. Cell pellets were washed
with sterile water twice and decanted under the same centrifugation conditions. The cell
pellets were then resuspended in 10 mL phosphate buffer solution (PBS) to obtain a final
cell counts of 6×108 CFU/mL.

2.3 Preparation of encapsulation matrix
Sodium alginate (Kimica Corp., Chuo-Ku, TY, Japan) of grade IL-1, potato starch
(Penford Food Ingredients Company, Centennial, CO), and type 4 resistant starch (RS4)
(Fibersym® RW, MGP Ingredients, Atchison, KS) were obtained from commercial
sources. Different combinations of matrix materials were tested. The total solid content
for all combinations was always maintained at 5% (w/v). Within this 5%, alginate content
ranged from 1.6% to 4.4% (w/v), and the ratio of potato starch and RS4 was fixed at 2:1.
All the combinations were displayed in Table 2.1. Thermal properties of potato starch
and RS4 were measured using differential scanning calorimetry (DSC). Based on the
thermal data, the mixture was heated to 85° C in preparation for use.

2.4 Preparation of particles using the emulsion method
The cell suspension was first mixed well with encapsulating material (1:5). The mixture
was then pumped through a rubber tube into Hyvee soybean oil (Hyvee Inc., West Des
Moines, IA) using a 101U/R pump (Watson-Marlow, Wilmington, MA) at 1.5 mL/min.
A gauge-15 needle was connected at the end of the tube to drip the mixture into 250 mL
soybean oil containing Tween 80 (0.2%, v/v) (Fisher Scientific, Hampton, NH) which
was stirred at 450 rpm by a magnetic stirrer. A water/oil emulsion was formed.

After the dripping was completed, 10 parts of calcium chloride (0.1M) (Aldrich Chemical
Company Inc., St. Louis, MO) was added along the side of the beaker to the emulsion
fast but gently (>20 mL/s) thus breaking the water/oil emulsion. The mixture was agitated
for 30 min to allow the particles to form. After the mixing was finished, the mixture was
left to stand for 60 min. During this period, phase separation occurred as the particles
with encapsulated L. acidophilus started to precipitate and fall to the bottom.

To collect the particles, the oil phase at the top was drained and the clear solution at the
bottom was centrifuged (350g×g, 15 min). The particles were washed twice with sterile
water and decanted under the same centrifugation conditions and then collected for use.
The picture of the particles observed under microscopy is shown in Figure 2.2

2.5 Preparation of particles using extrusion method
The encapsulation matrix material and the cell suspension mixture (1:5) was pumped in
the same way as described for the emulsion method using a needle (gauge 25) directly
into calcium chloride (0.1M), which was stirred at 200 rpm by a magnetic stirrer. The
distance between the needle and the calcium chloride solution was fixed at 3cm. Particles
were immediately formed when the mixture came in contact with the calcium chloride
solution. The solution was left to mix for 30 to 120 min to allow for the hardening of the
particles. The particles were then collected by filtration using cheesecloth which was
sterilized in boiling water for 12 min ahead of use. The particles were then washed with
sterile water and collected for the following tests. The picture of the particles observed is
shown in Figure 2.3.

2.6 Analysis of physical properties of particles
Particle size analysis of the particles from emulsion method was performed using a
Malvern Mastersizer 3000 laser diffraction particle size analyzer, equipped with a Hydro
MV wet dispersion unit (Malvern instruments Ltd., Malvern, Worcestershire, UK).
Analytical parameters were set per the manufacturer’s database as follows: refractive
index of 1.0, density of 1.0 g/cm3, mixing speed of 2300 rpm, feed rate of 50%, and
absorption index of 0.10. The particles were added into the wet dispersion cell until the
obscuration reading became steady (within the limit of 0.1-20%). Data was analyzed
using Malvern software (Version 2.20, Malvern instrument Ltd., Malvern, UK).

The size of the particles from extrusion method was measured using a caliper (Mitutoyo,
Aurora, IL). A single particle was placed between the jaws of the calipers to measure its
diameter. Measurements were performed in triplicate.

2.7 Release and enumeration of the encapsulated cells
Encapsulated cells were released from the particles before enumerating. For the particles
obtained with the emulsion method, 1 g of particles were added into 9 mL of potassium
phosphate buffer (0.1M, pH 7.0). Then it was macerated using a tissue homogenizer. For
the particles obtained with the extrusion method, 1 g of particles were added into a
stomacher bag with 9 mL of potassium phosphate buffer (0.1M, pH 7.0). It was then
blended in stomacher 400 (Seward, UK) gently for 10 min. An aliquot of 1 mL of the
suspension obtained from both methods was serialy diluted for plating. Released cells
were enumerated by spreading 100 µL of the diluted suspension into MRS plates and
incubating for 48 hours at 37°C anaerobically.

2.8 Optimization of encapsulation matrix material composition
The optimum matrix material composition was determined by comparing the cell
survivability of encapsulated cells with free cells after incubation in pH 2.0 MRS broth at
37°C for 3 hours. MRS broth was adjusted to pH 2.0 using 3.0 M hydrochloric acid
(Sigma Aldrich, St. Louis, MO). An aliquot of 9 mL of adjusted broths were added into

sterile 15 mL centrifuge tubes. Either 1 g of encapsulated particles or 1 mL of washed
cell suspension were added into the prepared tubes tempered at 37°C and vortexed for
complete dispersion. The tubes were then incubated at 37°C. One tube was immediately
sampled, and then another one after 3 hours for cell enumeration. The samplings were
performed in triplicate.

The harvesting of the particles from the emulsion method, or the extrusion method, and
free cells used in this experiment were performed as follows. As already mentioned, to
harvest the particles from the emulsion method, each tube was centrifuged (350×g, 8
min), the supernatant decanted, and the remaining pellets washed with sterile water twice
with water removed under the same centrifugation conditions. For the particles from the
extrusion method, they were harvested by filtration using cheesecloth and washed with
sterile water. To harvest the 48 hour cultured free cells, each tube was centrifuged
(2780×g, 8 min), the supernatant poured out, and the remaining pellet washed twice with
sterile water.

At time zero and after incubation time, all enumerations were performed as described
under section 2.7, for encapsulated cells. The tubes with free cells were centrifuged
(2780×g, 8 min) to recover a pellet that was resuspended in 1 mL of PBS. Aliquots of 0.1
mL were then used for serial dilutions. Viable counts were enumerated by spread plating
on MRS agar after anaerobic incubation for 48 hours at 37°C.

2.9 Acid and bile salt resistance of optimized particles
Particles produced by the emulsion and the extrusion method using the optimum
composition of the encapsulation matrix material were tested for acid and bile salt
resistance and compared to the survivability of free cells. MRS broth without addition of
acid or bile salt was used as a control. For the treatments, MRS broth was adjusted to pH
of 2.0, 4.0, and 7.0 using 3.0 M hydrochloric acid, and 0.5, 1, and 2% bile salt (Sigma
Aldrich, St. Louis, MO). The adjusted broths were added into sterile 15 mL centrifuge
tubes in 9-mL aliquots. Either 1 g of encapsulated particles or 1 mL of washed cell
suspension were added into the prepared tubes tempered at 37°C and vortexed for
complete dispersion. The tubes were then incubated at 37°C. One tube was immediately
sampled, and then another at 6, 15, and 24 h for a total of four tubes. During each time
point, all tubes, sampled or not sampled, were shaken gently. The samplings were
performed in triplicates and enumeration of viable cells was performed using the same
procedures described in Sections 2.7 and 2.8.

2.10 Resistance of optimized particles to temperature
Particles produced by the emulsion and the extrusion method using the optimized
encapsulation material were tested for their viability at 25, 37, and 50°C and compared to
free cells. Either 1 g of encapsulated particles or 1mL of L. acidophilus suspension were
added into tubes containing 9 mL of MRS broth. The tubes were incubated at 25, 37, and
50°C for 24 hours. Samplings were performed initially and after 24 hours using the same
harvest, release and plating procedures described in Sections 2.7 and 2.8.

2.11 Survivability test of optimized particles
Based on results obtained with the pH experiments, the hardening time of the extrusion
method was determined to be 120 min. Particles produced with the optimized
composition for encapsulation using the extrusion method were tested under different
conditions for a week. MRS broth without addition of acid was used as control. Tubes
with 9 mL MRS broth adjusted to pH of 4.0, 4.5, and 5.0 using 3.0 M hydrochloric acid
were also prepared. Each tube was added with 1 g of encapsulated particles. Enough
tubes were prepared to allow the removal of one tube for each pH at each sampling time.
Samplings were performed initially and then daily, for 7 days at 7 and 25°C, in triplicate.
Encapsulated cells were enumerated as described in sections 2.7 and 2.8 on MRS plates
after incubation anaerobically for 48 hours at 37°C. The limit of detection of the method
was <100 CFU.

2.12 Shelf life test of optimized particles
Commercial products tested were Hyvee 2% reduced milk (Hyvee, West Des Moines,
IA), V8 acai juice (Campbell’s Camden, NJ). They were pasteurized in 80°C water bath
for 12 minutes to kill all the vegetative cells present in the products. They were then put
into ice for cooling down. Particles produced using the optimized matrix composition
from the extrusion method were added to the pasteurized products (1 gram/10 mL).
Samplings were performed initially and then after 4, 8, 12, 16 days. Encapsulated cells
were enumerated as described in sections 2.7 and 2.8 on MRS plates after incubation
anaerobically for 48 hours at 37°C.

2.13 Statistical analysis
This study was performed using a completely random design (CRD). Analysis of
variance and mean differences were analyzed using SAS 9.4 (SAS Inc., Cary, NC) and
JMP 10.0.0 (SAS Institute Inc., Cary, NC). All tests were conducted at a 5% level of
significance.

Table 2.1. Selected compositions of encapsulating material used for the extrusion and
enumeration methods.
Alginate(%,w/v)
Potato starch: RS4 Ratio
1.6
2:1
3
2:1
4.4
2:1
*Total starch+ alginate= 5% (w/v). All samples were prepared in triplicate.
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Figure 2.2 Particles obtained using emulsion method under microscopy.

Figure 2.3 Particles obtained using extrusion method.

Chapter 3 Results and discussion
3.1 Emulsion method
3.1.1 Choosing wall material composition
Based on preliminary results (appendix A and B), selected wall materials and
compositions were chosen to study which compositions would provide the most
protection to the probiotic cells. For the experiments, alginate levels ranged from 1.6 to
4.4%, while the potato starch and RS4 ratio was fixed at 2. Encapsulated particles were
obtained with different wall material compositions with an emulsion method.
Encapsulated particles were incubated in MRS broth at pH 2 for 3 hours and tested for
the viability of the probiotic. The wall material compositions and the results obtained for
cell survivability are presented in Table 3.1.

Table 3.1 Bacterial cell reduction in encapsulated L. acidophilus when particles were
obtained by the emulsion method after 3 hours incubation in MRS broth at pH 2.
Wall material composition
Reduction (log CFU/g)
Alginate (%)
Potato starch: RS4
Mean (SD)
1.6
2
3.08 (0.05)a
3
2
2.78 (0.09)ab
4.4
2
2.31 (0.38)b
Free Cells
2.07 (0.25)b
*Different letters within the same column indicate difference based on p<0.05.
*Mean and standard deviation was obtained with triplicate samples.

The results showed that the least amount of bacterial reduction was achieved with either
free cells, 3.0 or 4.4% alginate, with no significant difference between the three

compositions (p>0.05). However, the survival of the bacterial cells encapsulated with
3.0% alginate was not different than the reduction observed in particles made with 1.6%
alginate. Therefore, from an economical stand point, the wall material composition of
1.6% alginate and potato starch: RS4 ratio of 2 was chosen for further tests.

3.1.2 Physical properties of encapsulated particles
The particle size distribution of encapsulated particles was determined for different wall
material compositions, with alginate varying from 1.6 to 4.4% and the ratio between
potato starch and RS4 fixed at 2. Results in Figure 3.1 show that particles prepared with
3.0 and 4.4% alginate showed one peak, while particles with 1.6% alginate showed two
peaks. Based on the results, particles with higher alginate level were larger in size. At an
alginate level of 1.6%, over 90% of the particles had a mean size of 666µm, while at an
alginate level of 3.0%, over 90% of the particles had a mean size of 586µm. Finally, at an
alginate level of 4.4%, over 90% of the particles had a mean size of 586µm.

Previous research had reported results regarding levels of alginate and particle size
distribution. Sheu and Marshall (1993) used light microscopy to measure the particle size
of encapsulated particles. They reported that the particles containing lactobacilli ranged
in size from 5-100 µm with means of 25-35µm. When the alginate increased from 0.5 to

4.5%, the mean particle size increased from 15.4 to 22.1µm. Adhikari et al. (2003)
measured particles containing B. longum B6 with laser diffractometry and found that the
particle size was 235.8±25.6 µm, with 91% in the size range of 22 to 350µm.
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Figure 3.1 Particle size distribution of particles produced by the emulsion method (1.6%,
3.0%, 4.4%- alginate level; potato starch: RS4=2).

3.1.3 Challenging encapsulated L. acidophilus with pH, bile salt and
temperature
Encapsulated cells were obtained using the optimized composition for the wall material.
The survivability of L. acidophilus in the particles after treatment at different pH,

different concentrations of bile salt and temperature was compared to free cells. To test
the performance of the encapsulated and free cells at different pH values, they were
incubated in MRS broth adjusted to pH 2, 4, and 7. Cell viability was tested after 6, 15,
and 24 hours. Viability at pH 2 and 4 appeared to decrease as the incubation period
increased (Figure 3.2). However at pH 7, L. acidophilus showed growth over the
incubation period, with both encapsulated and free cells. Encapsulated cells increased 1.3
log CFU/mL more than free cells. At acidic pH values, encapsulated cells showed a
reduction of 1.18 log CFU/g after 24h of incubation at pH 4, while free cells showed a
decrease of 2.91 log CFU/mL. Incubation of encapsulated and free cells at pH 2 showed
that both types of cells did not survive after 24 hours of incubation.

12
10

Log (cell count) cfu/g

8

pH2-en
ph4-en

6

ph7-en
ph2-un

4

ph4-un
ph7-un

2

control

0
0
-2

5

10

15

20

25

Time of incubation (h)

Figure 3.2 Survivability of encapsulated and free L. acidophilus over 24 hours of
incubation at different pH values.

These results show that encapsulation by emulsion has only a minimal effect in
protecting L. acidophilus from the effects of low pH. Encapsulation somewhat protected
cells at pH 4, but failed to protect the cells at pH 2. These results are in accordance with
previous published information. Rao et al. (1989), Hansen et al. (2002), Sultana et al.
(2000), Koo et al. (2001) reported that encapsulation did not provide protection against
acidic conditions as low as pH 2. However, Sultana et al. (2000) tested the acid tolerance
of encapsulated particles at pH 4 after incubation for 3 hours and found 1.71 log CFU/g
reduction while the free cells showed almost a 5 log decrease.

30

Survival of encapsulated cells and free cells was also tested after 6 hours of incubation in
MRS broth containing bile salt (0.5, 1.0, and 2.0%). Results shown in Table 3.2 suggest
that encapsulation may have provided some protection against bile salt; however
statistical analysis showed no difference between reductions obtained with encapsulated
and free cells. The encapsulated cells showed a 0.41 log reduction when exposed to 0.5%
bile salt broth, while the free cells decreased by 1.36 log. The results from 1.0% and
2.0% bile salt broth showed similar trends, where encapsulated cells were reduced by
about 0.70 log and free cells by 1.70 log.

Table 3.2 Reduction in bacterial counts of encapsulated and free L. acidophilus over 6 hours of incubation in
levels (0.5, 1.0, and 2.0%).
Bile salt (%)
Encapsulated (log CFU/g)
Free (log CFU/mL)
Initial
6 hours
Reduction
Initial
6 hours
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
b
0.5
6.54 (0.54)
6.13 (0.71)
0.41(0.20)
6.65 (0.18)
5.29 (0.21)
1.0
6.54 (0.54)
5.79 (0.67)
0.75(0.34)ab
6.65 (0.18)
4.95 (0.31)
ab
2.0
6.54 (0.54)
5.85 (0.79)
0.68(0.75)
6.65 (0.18)
4.89 (0.34)
*Different letters within the same row indicate difference based on p<0.05.
* Mean and standard deviation were obtained from triplicate samples.

bile salt at different
Reduction
Mean (SD)
1.35 (0.26)ab
1.69 (0.37)a
1.75 (0.24)a

Survival of encapsulated and free cells at different temperatures was also tested after
incubation in MRS broth at 25°C for 24 hours (Table 3.3), at 37°C for 24 hours (Table
3.4), and at 50 °C for 3 hours (Table 3.5). Cell counts were determined either initially and
after incubation periods or at set intervals. These results show that none of the
temperature was detrimental to either encapsulated or free cells. Actually, bacterial
growth was observed in encapsulated and free cells when incubated at 37°C. The cell
count of encapsulated and free cells remained stable at 25°C and 50°C. Ding and Shah
(2007) found that encapsulated L. acidophilus cells obtained from emulsion method died
after exposure to 65°C for up to1 hour, indicating that 65°C was the lethal temperature
for this organism and encapsulation did not improve heat tolerance.
Table 3.3 Survival of encapsulated and free L. acidophilus after incubation over 24 hours
incubation in MRS broth at 25°C.
Bacterial count (log CFU/g)
Bacterial reduction
(log CFU/g)
Initial
3 hours
Mean (SD)
Mean (SD)
Mean (SD)
Encapsulated
6.54 (0.54)
6.85 (0.76)
-0.18 (0.27)a
Free
6.65 (0.18)
6.49 (0.22)
0.15 (0.12)a
*Different letters within the same column indicate difference based on p<0.05.
* Mean and standard deviation was obtained with triplicate samples.

Table 3.4 Survival of encapsulated and free L. acidophilus over 24 hours incubation in
MRS broth at 37°C (log CFU/g).
Bacterial counts (log CFU/g)
Bacterial reduction
(log CFU/g)
Initial
6 hour
15 hour
24 hour
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Mean (SD)
Encapsulated 6.54 (0.54) 7.58 (0.15) 8.14 (0.80) 8.52 (1.08)
-1.97 (1.62)a
Free
6.65 (0.18) 7.45 (0.26) 8.42 (0.30) 8.97 (0.53)
-2.29 (0.63)a
*Different letters within the same column indicate difference based on p<0.05.
* Mean and standard deviation was obtained with triplicate samples.

Table 3.5 Survival of encapsulated and free L. acidophilus over 3 hours incubation in
MRS broth at 50°C (log CFU/g)
Initial
3 hours
Bacterial
reduction
Mean (SD)
Mean (SD)
Mean (SD)
Encapsulated
6.54 (0.54)
6.40 (0.69)
0.14 (0.31)a
Free
6.65 (0.18)
6.17 (0.14)
0.46 (0.30)a
*Different letters within the same column indicate difference based on p<0.05.
* Mean and standard deviation was obtained with triplicate samples.

Based on the results obtained and lack of evidence that encapsulation by emulsion was
efficient in promoting cell survivability at low pH, and a only a limited effect impacting
against bile salts was observed, this method of encapsulation was not further studied.

3.2 L. acidophilus encapsulated by the extrusion method
3.2.1 Wall material composition
Based on preliminary experiments, selected wall materials and compositions were chosen
that would provide the most protection to the probiotic cells. For these experiments,
alginate levels ranged from 1.6 to 4.4%, while the ratio of potato starch and RS4 was
fixed at 2. Encapsulated particles of different wall material compositions were obtained
using the extrusion method. Viability of bacterial cells was tested initially and after 3
hours of incubation in MRS broth at pH 2. The wall material compositions and the results
obtained for cell survivability are presented in Table 3.6.

Table 3.6 Bacterial cell reduction in encapsulated L. acidophilus after 3 hours incubation
in MRS broth at pH 2 when particles were obtained by the extrusion method.
Encapsulated cells
Bacterial reduction (log CFU/g)
Alginate (%)
Potato starch: RS4
Mean (SD)
1.6
2:1
0.29 (0.06)b
3.0
2:1
0.08 (0.09)bc
4.4
2:1
0.02 (0.12)c
Free cell
2.07 (0.25)a
*Different letters within the same column indicate difference based on p<0.05.
* Mean and standard deviation was obtained with triplicate samples.

These results showed that there was a significant difference in survivability between
encapsulated and free cells (p<0.05), indicating that encapsulation by extrusion could be
beneficial. Among alginate levels tested there was no difference between 1.6% and 3.0%.
However, there was a significant difference between 4.4% and 1.6% level of alginate.
Based on these results, to obtain the most protection by encapsulation, 4.4% of alginate
and 2:1 ratio of potato starch: RS 4 were chosen as the optimum wall material
composition.

3.2.2 Particle size
The size of the particles encapsulated by the extrusion method was measured and the
results are shown in Table 3.7. The results indicated that the mean particle diameter
ranged from 1.22 to 2.61mm when alginate concentration ranged from 1.6 to 4.4%. It
also indicated that the particle mean diameter would increase with increasing alginate
concentration. However, no statistical difference was observed among the values
measured.

The size of the particles produced by extrusion are influenced by factors such as
concentration of the alginate solution, distance between the syringe and hardening
solution, and the size of the needle (Smidsrod and Skjakbraek 1990). By comparing
results with published research done with same the syringe gauge and alginate solution
used here, similar results were found. Lee and Heo (2000) reported obtaining particles
with diameters of about 1.03, 1.75, 2.62 mm containing 2, 3, 4% sodium alginate,
respectively, which also increased with higher alginate concentration.

Table 3.7 Particle size (mean diameter) of the encapsulated particles from extrusion.
Wall material composition
Particle size (mm)
Alginate (%)
Potato starch: RS4
Mean (SD)
1.6
2
1.22 (0.01)ab
3
2
2.02 (0.01)a
4.4
2
2.61 (0.02)a
*Different letters within the same column indicate difference based on p<0.05.
* Mean and standard deviation was obtained with triplicate samples.

3.2.3 Hardening time test
Particles were made with the optimized wall material (4.4% alginate, potato starch:
RS4=2) and hardened for different time periods (30, 60, 90, and 120 min). Particles were
then tested for the survivability of encapsulated cells by incubating in MRS broth at pH 2
for 3 hours. The results shown in Table 3.8 indicated that as the hardening time increased,
the survival of bacterial cells in the particles started to increase as well. The viability of

the encapsulated cells in pH 2 decreased by 1.74 log with a 30 min hardening time which
was a significantly higher difference in reduction than the other ones observed with
longer hardening times (p<0.05). The reduction in all viability at pH 2 was 0.99, 0.55,
0.078 log CFU/g, for a hardening time of 60, 90, 120 min, respectively. Based on the
statistical analysis, a hardening time of 120 min was chosen as the optimum processing
parameter for the production of the particles.

The results observed here are in accordance with previous research. Chandramouli et al.
(2004) tested the hardening time when encapsulating L. acidophilus CSCC 2400 with
alginate, and found a significant increase in survival of bacteria cells when hardening the
particles for 30 min or more in 0.1M calcium chloride solutions. They also indicated that
hardening for 8 hours or more had no effect on increasing viability of the encapsulated
cells. Also, hardening particles for 12 hours at 4°C did not significantly influence
viability of encapsulated cells.
Table 3.8 Effect of hardening time on survival of encapsulated and free L. acidophilus
after incubation in MRS broth at pH 2 for 3 hours.
Hardening time (min)
Initial
3 hours
Reduction
(log CFU/g)
(log CFU/g)
(log CFU/g)
Mean (SD)
Mean (SD)
Mean (SD)
30
7.43 (0.35)
5.48 (0.45)
1.74 (0.11)a
60
7.91 (0.12)
6.92 (0.31)
0.99 (0.11)b
90
8.04 (0.50)
7.49 (0.38)
0.55 (0.11)bc
120
8.63 (0.12)
8.55 (0.03)
0.02 (0.11)c
*Different letters within the same column indicate difference based on p<0.05.
* Mean and standard deviation was obtained with triplicate samples.

3.2.4 Challenging encapsulated L. acidophilus with pH and bile salt test
Survival of encapsulated and free cells after incubation in MRS broth at pH 2.0, 4.0, 4.5,
and 5.0 for 24 hours was evaluated and the results are presented in Figure 3.3. Both
encapsulated and free cells were stable at pH 4, 4.5, and 5.0 with no significant
differences between reductions obtained for encapsulated cells and free cells (p>0.05).
However, there was a significant difference between the survival of encapsulated and free
cells after incubation in pH 2 for 24 hours (p<0.05). Encapsulation remarkably improved
the acid tolerance of particles at pH 2.
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Figure 3.3 Effect of pH on survival of encapsulated cells (cell reduction) after incubation
in MRS broth at pH 2.0, 4.0, 4.5, and 5.0 for 24 hours.

Encapsulated and free cells were also exposed to different concentrations of bile salt (0.5,
1.0, and 2.0%) and were tested after 6 hours of incubation. The results in Table 3.9
indicate that encapsulation provided protection for the cells, since the survival of
encapsulated cells was significantly better (p<0.05) than that of the free cells.
Encapsulated L. acidophilus with initial cell load of 8.86 log CFU/g, showed only about
0.5 log reduction for all bile salt levels tested. The free cells however showed reduction
by 1.36-, 1.70-, and 1.76-log for 0.5, 1.0, 2.0% bile salt, respectively.

Table 3.9 Bacterial counts of encapsulated and free L. acidophilus over 6 hours of incubation in bile salt at different levels (0.5, 1.0,
and 2.0%).
Bile salt
Encapsulated (log CFU/g)
Free cell (log CFU/Ml)
(%)
Initial
6 hours
Reduction
Initial
6 hours
Reduction
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
b
0.5
8.86 (0.14)
8.36 (0.16)
0.50 (0.14)
6.65 (0.18)
5.29 (0.21)
1.36 (0.14)a
1.0
8.86 (0.14)
8.27 (0.11)
0.59 (0.14)b
6.65 (0.18)
4.95 (0.31)
1.70 (0.14)a
2.0
8.86 (0.14)
8.35 (0.02)
0.51 (0.14)b
6.65 (0.18)
4.89 (0.34)
1.76 (0.14)a
*Different letters within the same column indicate difference based on p<0.05.
* Mean and standard deviation was obtained with triplicate samples.

The results show that encapsulation by the extrusion method gives good protection
against bile salt. The results related to improved survivability of encapsulated cells
treated with bile salt obtained in this study are in accordance with previous published
research (Lee and Heo 2000; Sabikhi et al. 2010). Murata et al. (1999) found out that
there was a 1- and 0.8-log decrease of free L. acidophilus at 1.0% bile salt, while for
encapsulated cells there was a 0.5 and 0.3 log decrease, for strains CSCC 2400 and CSCC
2409 respectively, under the same conditions after 6 hours. It was reported that certain
stains of L. acidophilus had the ability of conjugating bile acid under anaerobic
environment (Gilliland and Speck 1977a). Kim et al. (2008) studied strain of L.
cidophilus ATCC 43121, which was proved by Gilliland and Walker (1990) to be
significantly better in bile tolerance than other cultures. Their results showed that
encapsulated cells survived better in 0.5% bile salt and the free cells decreased from 6.85log to 5.96-log, while the encapsulated cells were not affected.

3.2.5 Challenging survival of encapsulated L. acidophilus under different
pH and temperature conditions for 7 days
Because the results from the pH experiment were limited to 24 hours, the exposure time
to low pH was extended to 7 days to evaluate the long term effect of pH on encapsulated
cells. Encapsulated and free cells were incubated in MRS broth at pH 4.0, 4.5, 5.0 at 7
and 25 °C, and were tested every day for 7 days (Figures 3.5 and 3.6). The viability of
encapsulated cells remained at 8 logs for the 3 different pHs at 7°C. Meanwhile, the free
cells showed a slight decrease of 2.1-, 1.3-, 1.3-log CFU/mL for pH 4.0, 4.5, 5.0,
respectively, over time. There was significant difference between encapsulated and free
cells at pH 4 when incubated at 7°C (p<0.05). When incubation at 25°C was evaluated,
the encapsulated cells incubated at pH 4.5 and 5.0 remained stable, showing a slight
decrease of 1.7-and 0.7-log respectively, which was not significantly different from the
results obtained with free cells (p>0.05). Encapsulated cells incubated at pH 4.0 began to
die at day 2 and by day 7 a reduction of 5.1 log CFU/g was observed. Despite the 5.0 log
reduction, encapsulation was significant in protecting L. acidophilus from the effect of
pH 4.0 since free cells were completely inactivate by day 6 (p<0.05).
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Figure 3.4 Survival of encapsulated and free cells during incubation for 7 days at 7°C.
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Figure 3.5 Survival of encapsulated and free cells during incubation for 7 days at 25°C.

These results were encouraging because it showed that encapsulation may protect cells
long term, especially at pH 4.0 at 7 and 25°C. This may allow for the addition of
encapsulated probiotics to acidic beverages with pH around 4.0.

3.2.6 Survival of encapsulated L. acidophilus in low pH beverages
Particles were produced and put into food systems to evaluate their performance over a
16 day shelf life. Based on the results from pH tests over 7 days, encapsulation provided
good protection when particles were incubated at low pH conditions at 7 and 25°C.
Therefore, two different products within the same pH range were chosen along with these

storage conditions. The two products tested were milk (2% reduced milk, 7°C) and a fruit
juice (acai juice, 25°C). The particles were put into the products, stored, and tested for
cell viability after 0, 4, 8, 12, 16 days of shelf life. The results are shown in Table 3.10.

Table 3.10 Survival of encapsulated and free cells in milk and juice (log CFU/g).
Cell count (CFU/g)
Day0
Day4
Day8
Day 12
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Milk Encapsulated
8.81 (0.10)
8.71 (0.08)
8.30 (0.35)
7.54 (0.29)

Juice

Day 16
Mean (SD)
7.03 (0.08)

Cell reduction
(log CFU/g)
Mean (SD)
1.74 (0.21)b

Free

8.26 (0.23)

7.73 (0.32)

7.63 (0.17)

7.60 (0.06)

6.97 (0.00)

1.28 (0.33)b

Encapsulated

8.81 (0.10)

7.62 (0.10)

7.39 (0.11)

ND

ND

8.81 (0.12)a

Free

8.26 (0.23)

6.98 (0.13)

5.54 (0.19)

ND

ND

8.26 (0.33)a

*Different letters within the same column indicate difference based on p<0.05.
*Mean and standard deviation was obtained with duplicated sample.
*ND: None detected; limit of detection of <100 CFU.

The results indicated that both the encapsulated and free cells placed in milk stayed
stable. Encapsulated particles showed a decrease of 1.78 log CFU/g in milk after 16 days
of shelf life, while the free cells showed a decrease of 1.29 log CFU/mL. Overall, for the
particles in milk, the number of probiotics was maintained above the recommended
minimum (107 CFU/g) during storage, which was feasible for industry applications.

For the particles in acai juice, the results showed that both encapsulated and free cells
started to die at day 4. Encapsulation provided protection to some extent at day 4 and 8
with a 1.19 and 1.42 log CFU/g reduction for encapsulated cells, respectively; while free
cells suffered a reduction of 1.28 and 2.72 log CFU/mL. However, both encapsulated
and free cells completely died at day 12. One reason that may explain why both the
encapsulated and free cells died in the juice was that the pH of the beverage was even
lower than the pH tested in the MRS broth where protective effects had been observed.
The beverage also had a low concentration of calcium cation (2%), which can be
beneficial for the stability of the alginate network.

Similar results have been reported for encapsulated probiotics added to yogurt and stored
at 4°C. Krasaekoopt et al. (2006) tested the particles in yogurt made from UHT- and
conventional milk and found that encapsulated cells were reduced by about 1.2 log while

free cells showed a reduction of 2.5 log after 4 weeks of storage. Ding and Shah (2008)
tested encapsulated particles in orange and apple juices over 4 weeks of storage. They
found out that there was a rapid decrease of free cells within four weeks and all the free
cells died by the fifth week. The encapsulated cells were still detected as high as 105
CFU/g after 6 weeks of storage. The reason why the previous results showed a higher
survival of the cells might be due to the type of the juice used and strain of the organism.
The free cells were still alive by the fifth week while the L. acidophilus DDS 1-10 died
on day 12 (week 2), which indicates that the organism they used were more resistant to
low pH. Therefore, even though previous research also showed a decline in survivability,
the rate of cell death was slower than observed in this research.
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Chapter 4 Conclusions and future research
4.1 Conclusions
Alginate-starch matrices were used to encapsulate L. acidophilus DDS 1-10 using an
emulsion and an extrusion method. For the emulsion method, the optimum wall material
composition was 1.6% of alginate and potato starch: RS4 in a ratio of 2:1. Particles
obtained with this method showed a particle size distribution that was not uniform. The
encapsulation process did not seem to enhance the bacterial resistance to acid conditions.
Encapsulation by emulsion provided small but not significant protection against bile salt
(0.5, 1.0, and 2.0%) for up to 6 hours. Regarding temperature, none of the different ones
tested (25, 37, and 50 °C) was lethal to L. acidophilus (encapsulated and free cells), so
heat protection by encapsulation was not be observed. Since the encapsulated particles
did not seem to offer additional protection against pH and bile salts, the emulsion method
was not studied any further.

The extrusion method seemed to overall provide a better protection for L. acidophilus
compared to the emulsion method. For this process, the optimum wall material was
determined to be 4.4% of alginate and potato starch: RS 4 in a ratio of 2:1. The particles
produced by extrusion were bigger in size than the ones produced by the emulsion
method, but much more uniform, with a mean diameter of 2.61 mm. The hardening time
used to produce the particles influenced the survivability of L. acidophilus in the

particles. Increasing the hardening time during processing, especially when increased to 2
hours, dramatically increased the stability of the probiotic in the particles. Additionally,
the encapsulated particles showed significant resistance to bile salt at 0.5, 1.0, and 2.0%
after 6 hours of incubation. When incubation at pH 4.0, 4.5, and 5.0 for 24 hours at 37°C
was evaluated, encapsulation did not provide any advantage; since both encapsulated and
free cells were stable. However, when the testing time was increased to 7 days and the
temperature was changed to 7 and 25°C, encapsulation was protective for the cells when
tested at pH 4.0 for both 7 and 25°C. These results indicated the potential to incorporate
these particles into a system with a pH around 4.0 followed by storage at 7 and 25°C.
When particles were incorporated into food systems, promising results were obtained
with milk. When incorporated into this food, the particles maintained counts above or at
the levels usually observed in foods added with probiotics during 16 days of storage.
However, the cells were not fully protected in acai juice over the storage period most
likely due to the low pH of the juice.

4.2 Future work
Areas of interest to continue with this research include:


Further optimization of the encapsulation processing by adding a second layer to
the existing wall material, i.e. chitosan, gelatin.



Further optimization of wall material compositions by including tests with higher
starch composition.



Evaluation of protection provided to L. acidophilus by encapsulation against acid
and bile using more complex models.



Evaluation of protection against temperature provided by encapsulation when
higher temperature and longer exposure time are used.



Freeze drying of the particles to evaluate the survival of L. acidophilus, with the
potential of adding the dried encapsulated probiotic to a wider variety of food
products.



Incorporation of encapsulated L. acidophilus in other dairy products, like cheese
and yogurt, as well as in juices with higher pH.



Shelf life of encapsulated cells.

Appendix A.

Note: The data in Appendix A and B was generated in an attempt to utilize a responsesurface design to find the best wall material combinations. The results were inconsistent
and did not show any obvious patterns. Therefore this design was abandoned and
replaced by a simple model that is described in the thesis under materials and methods.

Bacterial reduction of encapsulated particles produced from
emulsion method after incubation in MRS at pH 2 for 3 hours
Alginate (%)

Potato starch : RS4 Ratio

1.6
3
4.4
2
2
4
4
3
3

2:1
2:1
2:1
1:1
3:1
1:1
3:1
3:5
24:7

Reduction (log CFU/g)
Mean (SD)
3.08 (0.05)
2.78 (0.09)
2.31 (0.38)
1.36 (0.45)
2.79 (0.07)
2.47 (0.46)
1.58 (0.46)
3.17 (0.28)
3.32 (0.02)

*All samples were done with duplicate, 3% of alginate, ratio of potato starch: RS4 at 2:1 was
done with 5 runs.

Appendix B.

Bacterial reduction of encapsulated particles produced from
extrusion method after incubation in MRS at pH 2 for 3 hours.

Alginate

Potato: RS4 Ratio

1.6
3
4.4
2
2
4
4
3
3

2:1
2:1
2:1
1:1
3:1
1:1
3:1
3:5
24:7

Reduction (Log CFU/g)
Mean (SD)
2.09 (0.46)
1.97 (0.35)
1.74 (0.11)
1.87 (0.01)
1.66 (0.89)
1.90 (0.03)
1.28 (0.30)
2.23 (0.03)
2.10 (0.06)

*All samples were done with duplicate, 3% of alginate, ration of potato starch: RS4 at 2:1
was done with 5 runs.

